Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Submitted by
admin
on February 28, 2018 - 11:14am
Source:
Fierce Pharma
News Tags:
Japan
Shionogi
Flu
influenza
Xofluza
Headline:
Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019
Do Not Allow Advertisers to Use My Personal information
